Victor Sandor is Chief Medical Officer at ARRAY BIOPHARMA INC (ARRY). They have made 12 open-market trades across 2 companies since 2018, most recently 2026-06-03.
CIK 0001620368
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADCT | SELL | 2024-06-17 | 2024-06-18 | $2.89 | $20K | +38.3% | +38.0% | +15.8% |
| ARRY | SELL | 2019-06-04 | 2019-06-06 | $28.51 | $2.9M | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2019-05-30 | 2019-06-03 | $27.57 | $2.4M | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2019-05-23 | 2019-05-28 | $26.82 | $3.1M | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2019-05-21 | 2019-05-23 | $26.50 | $334K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-12-27 | 2019-01-02 | $14.05 | $176K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-12-03 | 2018-12-06 | $16.21 | $3.7M | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-09-04 | 2018-09-05 | $15.38 | $298K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-06-19 | 2018-06-21 | $18.76 | $2.9M | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-06-13 | 2018-06-15 | $18.75 | $420K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-04-03 | 2018-04-03 | $15.35 | $267K | +33.9% | +23.6% | +23.6% |
| ARRY | SELL | 2018-03-09 | 2018-03-09 | $17.71 | $5.5M | +33.9% | +23.6% | +23.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.